Image: Getty Images
The National Health Laboratory Service (NHLS) has ceased production of all snake, scorpion, and spider antivenom in South Africa due to ongoing construction at its facility, reports The Daily Maverick (DM)
This has led to a depletion of stockpiles, leaving hospitals and clinics critically understocked.
The NHLS states that infrastructure upgrades at the South African Vaccine Producers (SAVP) facility were necessary due to ageing equipment and compliance issues with Good Manufacturing Practices (GMP). However, unexpected delays in acquiring specialised equipment have prolonged the production halt.
South Africa’s polyvalent antivenom, used to treat bites from ten species, including black mambas, Cape cobras, and puff adders, is now unavailable. Only boomslang antivenom remains, but these bites are rare.
ALSO READ: Best snake identification resources to use in South Africa
There is also no longer any locally produced antivenom for scorpion stings and spider bites, DM adds.
As Southern Africa enters the second peak of snakebite season, it is expected that fatalities and severe complications will rise.
The Democratic Alliance has called for urgent accountability from the NHLS and an update on production timelines.
Even if production resumes immediately, it will take months before new stock is available, prolonging the crisis.
Follow us on social media for more travel news, inspiration, and guides. You can also tag us to be featured.
TikTok | Instagram | Facebook | Twitter
ALSO READ:
